Fairvalue-Calculator Fairvalue-Calculator
EN DE

Andromeda Metals Limited (ADN) Fair Value & Analysis

Basic Materials · AU · Market cap A$37.0M

PriceA$0.0060
Fair ValueA$0.0062
Upside+4.0%
Quality95/100
Evidence: Low

Fair value as of: Jun 26, 2026

Analysis

Andromeda Metals Limited (ADN) currently trades at A$0.0060, while our model-based Fair Value estimate is A$0.0062 — implying the stock looks roughly 4.0% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Andromeda Metals Limited operates as a mineral exploration company in Australia. The company explores for kaolinite, halloysite, and high purity alumina deposits. Its flagship project is the 100% owned Great White Project comprises three mining tenements and three exploration tenements located in the South Australia. The company was formerly known as Adelaide Resources Limited and changed its name to Andromeda Metals Limited in December 2016. The company was incorporated in 1993 and is headquartered in Adelaide, Australia.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Andromeda Metals Limited (ADN) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0062 versus a price of A$0.0060 — about +4% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ADN?
Our 21-model fair value for Andromeda Metals Limited is A$0.0062 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0060.
What is the quality score of ADN?
Andromeda Metals Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.